SAGA Diagnostics
SAGA Diagnostics is seeking a Principal Scientist specialized in high-throughput sequencing to lead the development and optimization of NGS-based assays for molecular residual disease testing. The role involves cross-functional collaboration, assay validation, and ongoing technological innovation in a clinical diagnostics setting.
Headquarters
Morrisville, North Carolina, United States
Company Size
11-50 employees
Founded
2016
SAGA Diagnostics is a molecular diagnostics company focused on redefining the early detection of molecular residual disease (MRD) to improve cancer care. They develop sensitive molecular assays and analytics designed to detect residual disease earlier and more reliably, helping clinicians assess response and risk. By delivering clearer MRD insights, SAGA aims to empower treatment decisions with greater confidence for clinicians, patients, and clinical trials.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for SAGA Diagnostics.
20% above the average for this role